Paclitaxel-Induced Pneumonitis in Trinidad: A Case Report

Paclitaxel-induced pneumonitis (PIP) is an immune-mediated disease resulting from a delayed hypersensitivity reaction (type IV) to paclitaxel, an anti-microtubule chemotherapeutic drug commonly used to treat breast cancer in both neoadjuvant and adjuvant settings. PIP is diagnosed by exclusion utili...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Nishtha, Dalip, Dominic, Rampersad, Fidel S, Jaggernauth, Shiva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357421/
https://www.ncbi.nlm.nih.gov/pubmed/35949737
http://dx.doi.org/10.7759/cureus.26613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357421/
https://www.ncbi.nlm.nih.gov/pubmed/35949737
http://dx.doi.org/10.7759/cureus.26613

Ejemplares similares